These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23828652)

  • 41. 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
    Samarin A; Hüllner M; Queiroz MA; Stolzmann P; Burger IA; von Schulthess G; Veit-Haibach P
    Nucl Med Commun; 2015 Dec; 36(12):1165-73. PubMed ID: 26397999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
    Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
    Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
    Kwee RM; Marcus C; Sheikhbahaei S; Subramaniam RM
    PET Clin; 2015 Apr; 10(2):197-205. PubMed ID: 25829086
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Prakash G; Singh N
    AJR Am J Roentgenol; 2019 Jan; 212(1):W10-W18. PubMed ID: 30383406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential values of metabolic tumor volume and heterogeneity measured with ¹⁸F-FDG PET/CT pretreatment to evaluate local control for esophageal squamous cell carcinoma treated with nonsurgical therapy.
    Liu Q; Fu XL; Yu W; Zhu ZF; Zhang YJ
    Nucl Med Commun; 2015 May; 36(5):423-9. PubMed ID: 25603275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
    Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solitary Retroperitoneal Metastasis as the Initial Site of the Relapse of Osteosarcoma Revealed by FDG PET/CT.
    Liu B; Yang H; Servaes S; Zhuang H
    Clin Nucl Med; 2015 Nov; 40(11):892-4. PubMed ID: 26018716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection of Primary Esophageal Carcinoma.
    Genc B; Kantarci M; Sade R; Orsal E; Ogul H; Okur A; Aydin Y; Karaca L; Eroğlu A
    Med Princ Pract; 2016; 25(3):254-9. PubMed ID: 26784024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
    Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chowdhury FU; Radhakrishna G; Godfrey EM
    Clin Radiol; 2013 Apr; 68(4):338-9. PubMed ID: 23164464
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.
    Cerci JJ; Pereira Neto CC; Krauzer C; Sakamoto DG; Vitola JV
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):98-103. PubMed ID: 23100050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
    Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.
    Morita M; Higuchi T; Achmad A; Tokue A; Arisaka Y; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1672-81. PubMed ID: 24006150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDG PET/CT Manifestation of Rare Widespread Metastatic Chemoradiation-Refractory Thymic Squamous Cell Carcinoma.
    VanDreel A; Patel D; Emmadi R; Lu Y
    Clin Nucl Med; 2015 Nov; 40(11):899-901. PubMed ID: 26252330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.